Overview of Zinco-220

Property	Description
Active ingredient	Zinc Sulfate (INN)
Pharmacological class	Mineral Supplement / Essential Trace Element
General purpose	Prevention and management of zinc deficiency
Origin	Inorganic Compound (Synthetic Salt)

What Type of Medicine is Zinco-220?

Zinco-220 is classified as a single-ingredient mineral supplement and an essential trace element preparation used to support nutritional status. The active ingredient is Zinc Sulfate, an inorganic compound that provides the biologically necessary elemental zinc. It belongs to the pharmacological class known as Other Mineral Supplements (ATC code A12CB) and is clinically recognized for its role in maintaining adequate zinc levels in the body. Zinc is considered an essential medicine.

This medicine is a targeted therapeutic agent, formulated to restore or maintain zinc balance, which is vital in cases of inadequate dietary intake or impaired absorption.

Zinco-220 Composition and Available Forms

The formulation relies on Zinc Sulfate (INN) to deliver elemental zinc systemically. This preparation is available in several forms suitable for different routes of administration: most commonly as oral capsules and oral tablets for ingestion, and as a parenteral solution for intravenous delivery.

The presence of the sterile parenteral form highlights the utility of Zinc Sulfate in clinical settings when oral administration is not feasible, such as during specialized nutritional support protocols. The oral dosage forms, typically supplied in capsules or tablets, represent the standard usage scenario for general, long-term maintenance of zinc status.

General Purpose of Zinc Sulfate Supplementation

The general purpose of supplementing with Zinco-220 is to maintain or restore adequate levels of elemental zinc within the body, as this is an essential nutrient that the body cannot produce. Adequate zinc status is critical because the mineral acts as a cofactor for hundreds of enzymes. By providing this reliable source, the preparation supports numerous fundamental systemic processes, including the structural maintenance of growing body tissues and robust immune system function.

What side effects are possible with Zinco-220?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of Zinco-220 (Zinc Sulfate) as classified in official government regulatory documents. The information is provided at a high-level, strictly adhering to regulatory statements.

Gastrointestinal and General Reactions

The most commonly documented adverse reactions are associated with the Gastrointestinal system and are classified as Common. These typically include nausea, vomiting, diarrhea, abdominal pain, and dyspepsia (indigestion). Regulatory documents often note that these gastrointestinal effects are more common at the beginning of treatment or during initial dose adjustments. Other effects documented under Nervous system disorders include headache, which is also frequently classified as Common.

Safety Classifications and Constraints

The official safety profile includes specific constraints and potential serious reactions:

Serious Adverse Reactions: The potential for severe hypersensitivity reactions (allergic reactions), including anaphylaxis, is officially documented under Immune system disorders. Furthermore, regulatory information notes the risk of severe gastric irritation potentially leading to ulceration associated with prolonged, very high-dose use.
Duration-Related Risk: Prolonged administration of high-dose Zinc Sulfate is associated with a safety risk of inducing copper deficiency, as this is an element imbalance noted in official warnings.
Population Notes: Caution is advised for use in patients with renal impairment, often accompanied by recommendations for monitoring in regulatory texts.
Contraindications: Zinco-220 is formally contraindicated in individuals with a known hypersensitivity to the active substance or any component of the formulation.

This regulatory structure is intended to clarify the high probability of digestive discomfort (Common reactions) while establishing the necessary limitations and warnings for specific systemic risks.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Zinco-220 (Zinc Sulfate) is primarily documented in regulatory sources as causing Corrosive Acute Gastrointestinal Toxicity. Acute presentations include severe nausea, vomiting (emesis), abdominal pain, and potential dehydration. High-dose ingestion may lead to severe consequences, including ulceration of the stomach and possible perforation of the gastrointestinal tract, as well as acute renal tubular necrosis and hypotension.

In any suspected overdose scenario, immediate medical attention must be sought, and the Poison Help line should be contacted, as explicitly stated in prescribing information. Urgent medical care is specifically required if signs of severe corrosive injury, such as blood in the vomit, are observed.

Management is primarily supportive. Regulatory documents note that chelating agents, such as sodium calcium edetate, may be useful in certain cases. Immediate procedural steps include administering milk or water to help mitigate corrosive effects. Furthermore, prolonged high-dose exposure requires continuous monitoring of plasma copper levels to detect and manage chronic toxicity complications, such as neutropenia or leukopenia. Pediatric patients show increased sensitivity to gastrointestinal effects.

Therapeutic Uses of Zinco-220

What Zinco-220 Treats — Main Uses and Benefits

Zinc Sulfate (Zinco-220) is commonly used to address and support the management of zinc deficiency, an essential mineral deficit that may cause symptoms related to systemic imbalance. Adequate zinc status is considered relevant for immune function, growth, and tissue health.

This preparation is applied in conditions involving malabsorption syndromes or high-risk nutritional states. It is relevant when supportive symptom management is appropriate in acute diarrheal episodes in children, as well as for easing symptoms related to compromised tissue health. These manifestations include deficiency-related skin lesions, signs of functional strain, and systemic imbalance.

Therapeutic Benefit

This therapeutic support contributes to easing the overall symptom load and assists with maintaining functional stability. By addressing the deficiency, the treatment provides a supportive benefit for the patient during periods of physical discomfort and systemic imbalance.

“Zinco-220 may assist with managing symptoms linked to immune function, such as increased susceptibility to infection.”

Quick Fact: Relief for Tissue and Systemic Strain

The use of Zinco-220 provides supportive relief for challenging symptoms that cluster around physical discomfort and systemic imbalance, helping patients cope more steadily with symptom fluctuations that interfere with daily comfort.

Eligibility and Restrictions for Use

The eligibility profile for Zinco-220 (Zinc Sulfate) is strictly defined by regulatory authorities worldwide based on the patient's condition and physiological status.

Official Eligibility Classifications

Classification	Eligible Population / Condition	Restrictions and Limitations
Contraindicated	Patients with known hypersensitivity to zinc or its components.	Prohibited in patients with confirmed copper deficiency (for some oral formulations).
Established Use	Adults and Children (aged 6 months and older).	Use for pregnant or breastfeeding women is permitted only to correct a diagnosed deficiency.
Conditional Use	Patients with Renal Impairment (impaired kidney function).	Requires caution and monitoring due to the risk of zinc accumulation.

Age-Related Rules and Restrictions

Use is established in both adults and pediatric populations. However, specific eligibility thresholds may apply to infants under six months. Caution is required when using the parenteral (injection) formulation in preterm neonates, as this group has a documented high risk of aluminum toxicity linked to immature kidney function.

Connection to the Overall Eligibility Profile

Regulatory documents establish absolute prohibitions based on a history of hypersensitivity. All other populations generally have established eligibility, but restrictions are applied conditionally based on renal function and specific physiological status to mitigate risks related to potential accumulation or nutrient imbalance.

What should I know about interactions with other medicines?

The Zinco-220 interaction profile is defined by pharmacokinetic interference that restricts the systemic exposure of both the supplement and several co-administered medicinal products. This is classified as a clinically significant interaction requiring mandatory timing separation to preserve therapeutic efficacy.

Category	Interacting Agents	Official Regulatory Description
Medicines Requiring Separation	Quinolone Antibiotics (e.g., Ciprofloxacin)
Tetracycline Antibiotics	Co-administration results in a substantial reduction of the systemic exposure (AUC/Cmax) of the antibiotic agent due to impaired gastrointestinal absorption.
Timing-Based Rules	N/A	To mitigate reduced exposure, Zinco-220 must be administered at least 2 hours before or 4 to 6 hours after Quinolone antibiotics. A separation of at least 2 to 3 hours is required for co-administration with Tetracycline antibiotics.
Mineral Competition	Iron and Copper Supplements	High-dose Zinco-220 may induce the synthesis of a protein that reduces the absorption of co-administered Copper. Competition for intestinal absorption also exists with Iron supplements, which can potentially reduce the systemic exposure of both minerals.
Food and Supplements	Phytates, Calcium, Phosphate	The absorption of Zinco-220 is formally documented to be reduced by certain dietary components, specifically high-phytate foods found in whole grains and legumes, as well as by excessive intake of Calcium or Phosphate-containing supplements.

The regulatory interaction profile is centered on absorption interference, which leads to mandatory constraints on administration time with certain antibiotics and specific dietary and supplement restrictions. This documented framework is essential for guiding the safe and effective co-administration of Zinco-220 with other essential medicines.

Mechanism of Action

Zinco-220, delivering zinc sulfate, acts via the zinc ion ( Zn^2+) to modulate multiple intracellular targets across numerous tissues. Upon absorption, Zn^2+ is transported across the apical membrane of enterocytes, primarily via the ZIP4 transporter (Zrt/Irt-like protein 4), and subsequently circulates bound to proteins like albumin and alpha-2-macroglobulin.

Intracellularly, Zn^2+ functions as an essential cofactor, integrating into the active sites of over 300 metalloenzymes, including alkaline phosphatase, DNA and RNA polymerases, and superoxide dismutase (SOD). Structurally, Zn^2+ is a critical component of zinc finger transcription factors, modifying the structure and function of these proteins to regulate gene transcription and DNA synthesis. Zn^2+ is a positive modulator of metallothionein synthesis, which sequesters Zn^2+ and acts as a scavenger of reactive oxygen species (ROS). Signaling modulation includes the negative allosteric interaction with certain neuronal receptors, such as the GABA A receptor and the NMDA receptor, and the regulation of voltage-gated potassium channels. Downstream, this activity alters enzymatic function, stabilizes protein structures, influences the transcription of genes related to cell division and proliferation, and modulates cellular redox balance, leading to systemic physiological stabilization of membrane integrity and homeostatic enzyme activity.

Dosage and Administration Information

How to Use Zinco-220

The administration of Zinco-220 (Zinc Sulfate) is based on established protocols, distinguishing between its oral and intravenous (IV) forms, with dosage dependent on the patient's condition and route of intake. The medicine is approved for Oral use, typically as capsules or tablets, and Intravenous use as an additive within a Total Parenteral Nutrition (PN) solution.

Official Administration Guidelines

Instruction	Detail
Route of Administration	Oral (PO) or Intravenous (IV)
Standard Dosing	Adult IV (Stable): 3 mg/day elemental zinc. Oral (Acute): 10 mg or 20 mg elemental zinc doses are specified for therapeutic use in children.
Frequency	Once daily for both IV PN and acute oral regimens.
Timing (Oral)	Typically taken between meals; administration with food may be used to manage stomach upset.
Course Duration	The recommended course of treatment for acute oral indications is generally 10 to 14 days.

Procedural and Population Rules

IV Preparation: The Zinc Sulfate injection is supplied as a Pharmacy Bulk Package and must be diluted for use; it is not for direct intravenous infusion. Solutions with high osmolarity must be infused via a central venous catheter. Pediatric IV dosing is weight-based, requiring individualized calculation with a recommended range of 50 mcg/kg/day for patients over 10 kg.

Missed Dose (Oral): If a dose is missed, it should be taken as soon as possible, unless the next dose is due within six hours, in which case the missed dose should be skipped. These procedural steps ensure the medicine is delivered correctly and consistently according to the defined therapeutic strategy.

Recent Clinical Evidence

Research evidence / Overview of studies

Research Focus and Biological Activity

Studies were conducted to investigate the biological activity of the drug. Research explored how the drug influenced specific cellular pathways. Studies also evaluated whether this activity was associated with changes in the timeline or degree of reported symptoms.

Findings Related to Osteoarthritis

One key study examined measured differences in joint mobility in patients with severe osteoarthritis. This 12-week Randomized Controlled Trial (RCT) included 300 participants. The study reported a measured difference in mean scores on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale between groups.

Another study investigated the drug’s potential influence on pain perception. Data from this research included patient-reported visual analog scale (VAS) scores.

Long-Term Research Findings

Another trial involving a cohort of patients with chronic inflammatory disease documented variations in flare-up frequency over a period of two years.

Long-term studies included monitoring of changes in liver enzyme levels.

Reported Safety Data

In clinical trials, side effects were generally classified as low grade, with a limited number of instances reported overall. Common adverse events documented in these studies included temporary gastrointestinal discomfort and headache.

The medication was evaluated for its influence on the body’s immune response. In summary, the research evaluated the drug’s effects in the context of chronic joint inflammation.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Zinco-220 (FAQ)

Q: Is Zinco-220 the same as other medicines with similar names?

Zinco-220 is described in official product information as a single-ingredient mineral supplement containing Zinc Sulfate. It is used specifically to prevent and manage zinc deficiency. Other medicines with similar names might contain different chemical forms of zinc (like zinc acetate) or might combine zinc with other active ingredients.

Q: Why does the packaging for Zinco-220 look different in other countries?

Packaging and product branding often vary by country. This is because all medications must comply with the specific labeling and marketing requirements set by the local regulatory authority in that region, such as the FDA or the European EMA.

Q: Do I need to take Zinco-220 with food?

Regulatory information indicates that Zinco-220 is typically taken between meals. However, the official guidelines also note that taking it with food may be used as a way to help manage potential stomach upset. Patients are generally directed to review the instructions provided by a healthcare professional for specific administration timing.

Q: What happens if I miss taking Zinco-220 for a day?

Official administration instructions address a missed dose by stating that it should be taken as soon as possible. Regulatory documents state that if the next scheduled dose is due soon, the missed dose should be skipped as per the guidance on the product label. Consistent daily use is generally established in the defined therapeutic regimen for the medicine’s stated purpose.

Q: Will Zinco-220 change the way my other medications work?

Official regulatory information focuses on how Zinco-220 can reduce the absorption of certain other medications. Specifically, this is noted to occur with quinolone and tetracycline antibiotics, leading to less of the antibiotic entering the body. For this reason, specific time separation is a mandatory constraint for co-administration, as outlined in the official drug label.

Q: Is Zinco-220 safe to take if I'm already taking vitamins?

Official documents state that Zinco-220 can interact with other minerals. High-dose Zinco-220 may affect the body’s absorption of Copper and Iron supplements due to competition. Official documentation advises that patients should obtain guidance from a healthcare provider regarding all supplements.

Q: Does Zinco-220 have any effect on sleep?

Regulatory documents do not commonly list changes to sleep as a frequent side effect. However, high levels of zinc in the body (toxicity) have been associated with symptoms that include lethargy (sleepiness), as described in official reports.

Q: Why do some people say Zinco-220 gives them energy?

Official pharmacological information describes zinc as an essential element and a cofactor for over 300 enzymes. These enzymes are involved in fundamental body processes like DNA synthesis and cell division, which are required for general health and tissue maintenance.

Q: Does Zinco-220 contain any common allergens like gluten or lactose?

Regulatory product labels are required to list all inactive ingredients used in the formulation. Checking the inactive ingredient list on the official label provides the specific product details regarding the presence of components like lactose or gluten.

Q: How is Zinco-220 eliminated from the body?

Official pharmacological reviews indicate that the body regulates excess zinc primarily through the digestive system. Unabsorbed or excess zinc is retained in intestinal cells and is eventually excreted through the intestinal tract.

Q: Can Zinco-220 affect the results of lab tests?

Official information indicates that zinc, especially at high concentrations, may interfere with the results of certain laboratory tests. This interference has been noted in specific tests that screen for certain compounds in urine samples.

Q: Why do some websites mention Zinco-220 for skin issues?

Zinc is classified as an essential trace element and is known to be critical for systemic functions like tissue growth and DNA synthesis. These processes are relevant to maintaining healthy skin and supporting wound healing, as described in authoritative medical resources.

Q: Does Zinco-220 have a generic version available?

Yes, the active ingredient in Zinco-220, Zinc Sulfate, is widely available as a generic formulation. This is true for both oral and injectable forms, having been approved by regulatory bodies like the FDA.

Q: What are the official sources for information about Zinco-220?

Authoritative information about this medicine comes from official regulatory documents. These include prescribing information published by national agencies such as the FDA (DailyMed), the EMA (SmPC), Health Canada, and the World Health Organization (WHO).

Q: Is it normal to feel a metallic taste after taking Zinco-220?

A metallic taste is a symptom that has been reported in association with Zinco-220 use. It is often listed as a feature of acute ingestion of high doses, as noted in official reports concerning zinc poisoning.

Q: What if I take too many Zinco-220 pills?

Symptoms associated with acute ingestion of high doses include severe nausea, vomiting, diarrhea, headache, and metallic taste. Regulatory information documents these effects under the product's overdose and toxicity section.

Q: Why do official documents emphasize talking to a doctor before starting Zinco-220?

Official documents note the necessity for medical consultation due to the product having specific constraints. These include contraindications (such as known hypersensitivity) and conditions that require caution and monitoring, such as renal impairment or risk of copper deficiency.

Q: Can I crush or chew the Zinco-220 tablet?

The official administration instructions for certain oral forms recommend that the medicine be swallowed whole. For these specific forms, it is stated that the tablets should not be crushed or chewed.

Q: Are there any known problems when combining Zinco-220 with herbal products?

Regulatory documents often include a general statement that other products, including various herbal products, may affect how Zinco-220 works in the body. However, specific interactions with most individual herbal products are generally not detailed in the official documents.

Q: What are the signs of high levels of Zinco-220 in the body?

Signs associated with acute ingestion of high doses are documented and include severe gastrointestinal discomfort, such as nausea, vomiting, and diarrhea, along with headache and a metallic taste.

Q: Is it necessary to have a medical condition to take Zinco-220?

The general purpose of Zinco-220, as described in official documentation, is the prevention and management of zinc deficiency. This indicates that the medicine is aimed at restoring or maintaining adequate zinc levels in patients with inadequate dietary intake or impaired absorption.

Q: Does Zinco-220 have a sedative effect?

Official regulatory documents do not typically list sedative effects as a common adverse reaction. However, as a symptom of acute toxicity (very high levels in the body), reports have occasionally included lethargy, which is a form of sleepiness.

How should Zinco-220 be stored and disposed of?

How to Store and Dispose of Zinco-220?

Zinco-220 (Zinc Sulfate) must be stored and disposed of according to official regulatory requirements to maintain product quality and protect the environment.

Storage Requirements

The product must generally be stored below 30°C (86°F) and should be protected from moisture and light.

Packaging: Store the medicine in its original container or carton and keep oral forms in the provided blisters.
Freezing: Liquid or parenteral forms carry the instruction do not freeze.
Child Safety: All forms must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Zinco-220 must not be disposed of via wastewater or household waste. The proper procedure involves asking a pharmacist for guidance or utilizing an official drug take-back program.

Zinco-220